Primary care providers' attitudes toward prostate cancer risk factors at a Veterans Affairs health care facility

Military Medicine

Volumn 170, Issue 2, 2005, Pages 154-157

  Ruff, Peter A ^a   Marotte, Jeffrey B ^b,c   Terris, Martha K ^a,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ANXIETY DISORDER; ATTITUDE; CANCER SCREENING; COMORBIDITY; FAMILY HISTORY; FEMALE; HEALTH CARE FACILITY; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL DECISION MAKING; PROSTATE CANCER; RACE; REVIEW; RISK FACTOR; SOLDIER; ARTICLE; CLINICAL PRACTICE; EPIDEMIOLOGY; ETHNOLOGY; GENERAL PRACTITIONER; GOVERNMENT; HEALTH PERSONNEL ATTITUDE; MASS SCREENING; MIDDLE AGED; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; PUBLIC HOSPITAL; STATISTICS; UNITED STATES; UTILIZATION REVIEW; VETERAN;

ADULT; AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; HEALTH CARE SURVEYS; HOSPITALS, VETERANS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 17844392633     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. American Urological Association: Prostate-specific antigen (PSA) best practice policy. Oncology (Huntingt) 2000; 14: 267-72, 277-78, 280.
2. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer. 2003. CA Cancer J Clin 2000; 53: 27-43.
3. Bahnson RR, Hanks GE, Huben RP, et al: NCCN practice guidelines for prostate cancer. Oncology (Huntingt) 2000; 14: 111-9.
4. Richie JP, Murphy GP, Walther P: Prostate cancer surgical practice guidelines: Society of Surgical Oncology practice guidelines. Oncology (Huntingt) 1997; 11: 907-12.
5. Mark DH: Mortality of patients after radical prostatectomy: analysis of recent Medicare claims. J Urol 1994; 152: 896-8.
6. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45: 1007-15.
7. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services, Ed 2. Baltimore, Williams & Wilkins, 1996.
8. Luttge S, Love N: Screening for prostate cancer: is it a service or a disservice? Postgrad Med 1996; 100: 90-2, 95-6, 101-2.
9. Richter F, Dudley AW Jr, Irwin RJ Jr, et al: Are we ordering too many PSA tests? Prostate cancer diagnosis and PSA screening patterns for a single VA medical center. J Cancer Educ 2001; 16: 38-41.
10. American Academy of Family Physicians: AAFP Reference Manual, 1997-1998, p 62. Kansas City. MO, American Academy of Family Physicians, 1998.
11. Rose VL: ACP issues guidelines on the early detection of prostate cancer and screening for prostate cancer. Am Fam Physician 1997; 56: 1674-5.
12. Ferrini R, Woolf SH: American College of Preventive Medicine practice policy: screening for prostate cancer in American men. Am J Prev Med 1998; 15: 81-4.
13. Littrup PJ: Prostate cancer in African-American men. Prostate 1997; 31: 139-41.
14. Brawley OW: Prostate cancer and black men. Semin Urol Oncol 1998; 16: 184-6.
15. Brawley OW, Knopf K, Thompson I: The epidemiology of prostate cancer: part II: the risk factors. Semin Urol Oncol 1998; 16: 193-201.
16. Pienta KJ, Esper PS: Risk factors for prostate cancer. Ann Intern Med 1993; 118: 793-803.
17. Key T: Risk factors for prostate cancer. Cancer Surv 1995; 23: 63-77.
18. Steinberg GD, Carter BS, Beaty TH, et al: Family history and the risk of prostate cancer. Prostate 1990; 17: 337-47.
19. Mettlin C, Natarajan N, Huben R: Vasectomy and prostate cancer risk. Am J Epidemiol 1990; 132: 1056-61.
20. Rosenberg L, Palmer JR, Zauber AG, et al: Vasectomy and the risk of prostate cancer. Am J Epidemiol 1990; 132: 1051-5.
21. Hayes RB, Pottern LM, Swanson GM, et al: Tobacco use and prostate cancer in blacks and whites in the United States. Cancer Causes Control 1994; 5: 221-6.
22. Honda GD, Bernstein L, Ross RK, et al: Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988; 57: 326-31.
23. Lotufo PA, Lee IM, Ajani UA, et al: Cigarette smoking and risk of prostate cancer in the Physicians' Health Study (United States). Int J Cancer 2000; 87: 141-4.
24. Armstrong Laboratory: Air Force Health Study: An Epidemiologic Investigation of Health Effects in Air Force Personnel following Exposure to Herbicides: Mortality Update 1996. Publication AL/AO-TR-1996-0068. Brooks Air Force Base. TX. Epidemiologic Research Division. Armstrong Laboratory, 1996.
25. Watanabe KK, Kang HK: Mortality patterns among Vietnam veterans: a 24-year retrospective analysis. J Occup Environ Med 1996; 38: 272-8.
26. Crane PJ, Barnard DL, Horsley KW, et al: Mortality of Vietnam Veterans: The Veteran Cohort Study: A Report of the 1996 Retrospective Cohort Study of the Australian Vietnam Veterans. Canberra, Australia, Department of Veterans Affairs, 1997.
27. Edlefsen KL, Mandelson MT, McIntosh MW, et al: Prostate-specific antigen for prostate cancer screening: do physician characteristics affect its use? Am J Prev Med 1999; 17: 87-90.
28. Lurie N, Margolis K, McGovern PG, et al: Physician self-report of comfort and skill in providing preventive care to patients of the opposite sex. Arch Fam Med 1998; 7: 134-7.
29. Tudiver F, Guibert R, Haggerty J, et al: What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting? J Fam Pract 2002; 51: 760.
30. Landon BE, Reschovsky J, Reed M, et al: Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians. Med Care 2001; 39: 889-905.
31. Moran WP, Cohen SJ, Preisser JS, et al: Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care 2000; 6: 315-24.
32. Lawson DA, Simoes EJ, Sharp D, et al: Prostate cancer screening: a physician survey in Missouri. J Community Health 1998; 23: 347-58.
33. Kripalani S, Weinberg AD, Cooper HP: Screening for breast and prostate cancer: a survey of Texas primary care physicians. Tex Med 1996; 92: 59-67.
34. Herman CJ, Hoffman RM, Altobelli KK: Variation in recommendations for cancer screening among primary care physicians in New Mexico. J Community Health 1999; 24: 253-67.
35. McNaughton Collins M, Stafford RS, et al: Age-specific patterns of prostate-specific antigen testing among primary care physician visits. J Fam Pract 2000; 49: 169-72.
36. Fowler FJ Jr, Bin L, Collins MM, et al: Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998; 104: 526-32.
37. Wasson JH, Bubolz TA, Yao GL, et al: Prostate biopsies in men with limited life expectancy. Eff Clin Pract 2002; 5: 137-42.
38. Volk RJ, Cantor SB, Spann SJ, et al: Preferences of husbands and wives for prostate cancer screening. Arch Fam Med 1997; 6: 72-6.
39. Collins MM, Fowler FJ Jr, Roberts RG, et al: Medical malpractice implications of PSA testing for early detection of prostate cancer. J Law Med Ethics 1997; 25: 234-42.
40. Physician Insurers Association of America Data Sharing Committee: Cumulative Data Reports, January 1, 1985-June 30, 1996. Rockville, MD, Physician Insurers Association of America, 1996.
41. Reeves JD, Schellhammer PF: Legal implications of prostate cancer: what you should know. Va Med Q 1993; 120: 77-9.
42. Wasson JH, Cushman CC, Bruskewitz RC, et al: A structured literature review of treatment for localized prostate cancer: Prostate Disease Patient Outcome Research Team. Arch Fam Med 1993; 2: 487-93.